DFX Intelligence

Data Factory

Delphi Diagnostics

Delphi Diagnostics is developing next-generation diagnostics to personalize breast cancer treatment decisions. Utilizing the Endocrine Activity Index, Delphi Diagnostics is providing new information to help healthcare providers optimize treatment decisions.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:29b6549b-b90e-42be-9ea0-16c04f42572a

Data as of Sep 17, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 19, 2026, 11:09 AM UTC and rebuilt at most every 15 minutes.

Relationships: 2
Dated events: 0
On other graphs: 0
Observed: Sep 15, 2026 to Sep 17, 2026
6 observations

Across DFX

This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 0
Investors: 2
People: 0
Website: delphi-diagnostics.com

Investors

Investor	Class	Fund	Partner	Role	Attribution
Digitaldx Ventures Management, LLC	Micro VC	n/a	n/a	unknown	Unknown
Fannin Advisory, LLC	Micro VC	n/a	n/a	unknown	Unknown

Relationships

Invested in (2)

← Digitaldx Ventures Management, LLCFirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
← Fannin Advisory, LLCFirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site

Dated events

No dated event names this entity yet.

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:29b6549b-b90e-42be-9ea0-16c04f42572a
First observed: Sep 15, 2026
Last observed: Sep 17, 2026 2 days ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.